Valuation

STESTERIS

StockNYSEİrlandaHealth careEU retail: available

7/10

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
Metric	STE	Sector median	vs median
P/E	26,3	15,6 · n=8	%69 above
P/B	2,9	2,3 · n=14	%27 above
P/S	3,5	3,5 · n=11	near the median
EV/EBIT	19,8	16,9 · n=7	%17 above
Free-cash-flow yield	%4,4	%5,0 · n=12	%12 below
Dividend yield	%0,90	%1,67 · n=58	%46 below
Return on equity	%11,4	%2,5 · n=14	%360 above
Return on invested capital	%9,9	%4,6 · n=11	%113 above
Gross margin	%44,4	%66,3 · n=8	%33 below
Net debt / EBITDA	0,86	—	—

Value factor: 36 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

Instrument	P/E	P/B	EV/EBIT	Free-cash-flow yield	Dividend yield	Smart Score
NVSNovartis AG	20,0	6,1	16,9	%6,3	%3,2	10/10
SNYSanofi	11,1	1,2	15,3	%8,3	%6,1	7/10
ALCAlcon	31,8	1,4	25,2	%5,6	%0,6	5/10
BNTXBioNTech SE	—	1,0	—	%1,4	%0,0	—/10
ICLRICON plc	307,9	1,4	56,6	%6,8	%0,0	3/10
CRSPCRISPR Therapeutics AG	—	2,8	—	−%7,6	%0,0	1/10
ABCLAbCellera Biologics	—	4,2	—	−%3,2	%0,0	1/10
ZLABZai Lab Ltd	—	4,2	—	−%5,5	%0,0	1/10
AUPHAurinia Pharmaceuticals	7,0	3,6	—	—	%0,0	—/10
NVCRNovoCure Limited	—	4,8	—	−%1,6	%0,0	2/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Haz 2026 · filed 07 Ağu 2026

Buradan sözleşmeden çıkın · AB tüketicileri: Bir satın alma işlemini iptal etmek için 14 gün.